Literature DB >> 15196967

Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells.

Takafumi Hasegawa1, Michiko Matsuzaki, Atsushi Takeda, Akio Kikuchi, Hirotoshi Akita, George Perry, Mark A Smith, Yasuto Itoyama.   

Abstract

Alpha-synuclein (alpha-syn) is a major component of inclusion bodies in Parkinson's disease (PD) and other synucleinopathies. To clarify the possible roles of alpha-syn in the molecular pathogenesis of neurodegenerative diseases, we have established a novel cellular model based on the differentiation of SH-SY5Y cells that overexpress alpha-syn. In the presence of ferrous iron, differentiation of the cells led to the formation of large perinuclear inclusion bodies, which developed from scattered small aggregates seen in undifferentiated cells. The iron-induced alpha-syn-positive inclusions co-localized largely with ubiquitin, and some of them were positive for nitrotyrosine, lipid, gamma-tubulin and dynein. Notably, treatment with nocodazole, a microtubule depolymerizing agent, interrupted the aggregate formation but led to a concomitant increase of apoptotic cells. Therefore, it appears that an intracellular retrograde transport system via microtubules plays a crucial role in the aggregate formation and also that the aggregates may represent a cytoprotective response against noxious stimuli. This cellular model will enable better understanding of the molecular pathomechanisms of synucleinopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196967     DOI: 10.1016/j.brainres.2004.04.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction.

Authors:  Violetta N Pivtoraiko; Adam J Harrington; Burton J Mader; Austin M Luker; Guy A Caldwell; Kim A Caldwell; Kevin A Roth; John J Shacka
Journal:  J Neurochem       Date:  2010-06-01       Impact factor: 5.372

Review 2.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

3.  Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.

Authors:  Frits Kamp; Nicole Exner; Anne Kathrin Lutz; Nora Wender; Jan Hegermann; Bettina Brunner; Brigitte Nuscher; Tim Bartels; Armin Giese; Klaus Beyer; Stefan Eimer; Konstanze F Winklhofer; Christian Haass
Journal:  EMBO J       Date:  2010-09-14       Impact factor: 11.598

4.  A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-02-02       Impact factor: 5.372

5.  Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.

Authors:  Maria Angeliki S Pavlou; Nicoló Colombo; Sandra Fuertes-Alvarez; Sarah Nicklas; Laura Gonzalez Cano; Maria C Marín; Jorge Goncalves; Jens C Schwamborn
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

6.  Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy.

Authors:  Masatoshi Konno; Takafumi Hasegawa; Toru Baba; Emiko Miura; Naoto Sugeno; Akio Kikuchi; Fabienne C Fiesel; Tsutomu Sasaki; Masashi Aoki; Yasuto Itoyama; Atsushi Takeda
Journal:  Mol Neurodegener       Date:  2012-08-14       Impact factor: 14.195

7.  Phytic Acid Protects against 6-Hydroxydopamine-Induced Dopaminergic Neuron Apoptosis in Normal and Iron Excess Conditions in a Cell Culture Model.

Authors:  Qi Xu; Anumantha G Kanthasamy; Manju B Reddy
Journal:  Parkinsons Dis       Date:  2011-02-07

8.  The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein.

Authors:  Takafumi Hasegawa; Masatoshi Konno; Toru Baba; Naoto Sugeno; Akio Kikuchi; Michiko Kobayashi; Emiko Miura; Nobuyuki Tanaka; Keiichi Tamai; Katsutoshi Furukawa; Hiroyuki Arai; Fumiaki Mori; Koichi Wakabayashi; Masashi Aoki; Yasuto Itoyama; Atsushi Takeda
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

9.  Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease.

Authors:  Bo Su; Haihua Liu; Xinglong Wang; Shu G Chen; Sandra L Siedlak; Eisaku Kondo; Raymond Choi; Atsushi Takeda; Rudy J Castellani; George Perry; Mark A Smith; Xiongwei Zhu; Hyoung-Gon Lee
Journal:  Mol Neurodegener       Date:  2009-07-23       Impact factor: 14.195

Review 10.  Glia and alpha-synuclein in neurodegeneration: A complex interaction.

Authors:  Dominik Brück; Gregor K Wenning; Nadia Stefanova; Lisa Fellner
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.